POLYCLONAL AND MONOCLONAL THYROID-NODULES COEXIST WITHIN HUMAN MULTINODULAR GOITERS

被引:112
作者
KOPP, P
KIMURA, ET
AESCHIMANN, S
OESTREICHER, M
TOBLER, A
FEY, MF
STUDER, H
机构
[1] INSELSPITAL BERN, DEPT INTERNAL MED, EXPTL ENDOCRINOL LAB, CH-3010 BERN, SWITZERLAND
[2] INSELSPITAL BERN, INST MED ONCOL, EXPTL ENDOCRINOL LAB, CH-3010 BERN, SWITZERLAND
[3] INSELSPITAL BERN, CENT HEMATOL LAB, CH-3010 BERN, SWITZERLAND
[4] UNIV BERN, TIEFENAUSPITAL, CLIN EXPTL RES LAB, CH-3010 BERN, SWITZERLAND
关键词
D O I
10.1210/jc.79.1.134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although somatic mutations have been identified in a subset of thyroid nodules, the pathogenesis of nodules in multinodular goiters remains unclear, Clonal analysis indicates whether a nodule arises from the polyclonal proliferation of a group of cells or forms a clone from a genetically altered cell. Individual thyroid nodules have been shown to be of polyclonal or monoclonal origin. In this study we examined the clonality of several different nodules in patients with multinodular goiters. Clonality was established using the X-chromosomal probe M27 beta, which detects a multiallelic polymorphism at the locus DXS255 in 90% of females. Twenty-five nodules from 9 multinodular goiters were analyzed; 9 nodules were polyclonal, and 16 were monoclonal. Three goiters contained only polyclonal nodules, whereas 3 contained only monoclonal nodules. Polyclonal and monoclonal nodules coexisted in 3 goiters. In 2 goiters, the monoclonal nodules were shown to derive from different progenitor cells. We conclude that polyclonal and monoclonal nodules may coexist in multinodular goiters and that monoclonal nodules can originate from different cells. The coexistence of polyclonal and monoclonal nodules suggests that different pathogenic mechanisms occur simultaneously or that monoclonal nodules emerge secondarily from a polyclonal population due to a growth advantage from a genetically altered cell.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 37 条
[1]   MORPHOLOGICAL AND FUNCTIONAL POLYMORPHISM WITHIN CLONAL THYROID-NODULES [J].
AESCHIMANN, S ;
KOPP, PA ;
KIMURA, ET ;
ZBAEREN, J ;
TOBLER, A ;
FEY, MF ;
STUDER, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03) :846-851
[3]   MONOCLONALITY AND ABNORMAL PARATHYROID-HORMONE GENES IN PARATHYROID ADENOMAS [J].
ARNOLD, A ;
STAUNTON, CE ;
KIM, HG ;
GAZ, RD ;
KRONENBERG, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (11) :658-662
[4]   METHYLATION PATTERNS AT THE HYPERVARIABLE X-CHROMOSOME LOCUS DXS255 (M27-BETA) - CORRELATION WITH X-INACTIVATION STATUS [J].
BOYD, Y ;
FRASER, NJ .
GENOMICS, 1990, 7 (02) :182-187
[5]   THYROID-GLAND - US SCREENING IN MIDDLE-AGED WOMEN WITH NO PREVIOUS THYROID-DISEASE [J].
BRANDER, A ;
VIIKINKOSKI, P ;
NICKELS, J ;
KIVISAARI, L .
RADIOLOGY, 1989, 173 (02) :507-510
[7]   PROGRESSION OF UREMIC HYPERPARATHYROIDISM INVOLVES ALLELIC LOSS ON CHROMOSOME-11 [J].
FALCHETTI, A ;
BALE, AE ;
AMOROSI, A ;
BORDI, C ;
CICCHI, P ;
BANDINI, S ;
MARX, SJ ;
BRANDI, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :139-144
[8]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[9]  
FEY MF, 1994, BLOOD, V83, P931
[10]  
FEY MF, 1993, CANCER RES, V53, P921